1.92 +0.30 (18.52%)
Pre-Market: 8:43AM EST
|Bid||1.60 x 500|
|Ask||1.80 x 900|
|Day's Range||1.62 - 1.80|
|52 Week Range||1.32 - 4.20|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
Minutes Confirm Alignment on Soleno’ s Planned Phase III Clinical Trial. Soleno In Process of Initiating Phase III Study. REDWOOD CITY, Calif., Feb. 20, 2018-- Soleno Therapeutics, Inc., a clinical-stage ...
Financing to Support Planned Phase III Clinical Program for DCCR in Prader-Willi Syndrome. REDWOOD CITY, Calif., Dec. 12, 2017-- Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing ...
NEW YORK, NY / ACCESSWIRE / December 11, 2017 / Soleno Therapeutics headed higher on Friday after its wholly-owned subsidiary Capnia Inc. entered into a joint venture with OptAsia Healthcare Limited of ...
The direct benefit for Soleno Therapeutics Inc (NASDAQ:SLNO), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-offRead More...
REDWOOD CITY, Calif., Dec. 08, 2017-- Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it, and ...
For long-term investors, assessing earnings trend over time and against industry benchmarks is more beneficial than examining a single earnings announcement at a point in time. Investors may find myRead More...
Soleno Therapeutics Inc (NASDAQ:SLNO), a biotechnology company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqCM. LessRead More...
If you are looking to invest in Soleno Therapeutics Inc’s (NASDAQ:SLNO), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...
Categories: Yahoo FinanceGet free summary analysis Soleno Therapeutics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Soleno Therapeutics, Inc. – Neogen Corporation, Chembio Diagnostics, Inc. and Neurotrope Inc (NEOG-US, CEMI-US and NTRP-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)